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Available online 18 November 2010Background: A subgroup of patients with an implantable cardioverter defibrillator (ICD)
experiences emotional distress. This may be related to partner factors. We examined the
impact of the personality of the partner (i.e., the distressed (Type D) personality) in
combination with that of the patient on anxiety and depression levels in ICD patients.
Methods: Consecutively implanted ICD patients (N=281; 80.1% men; mean age=58.3±11.0)
and their partners (N=281; 20.6% men; mean age=56.5±11.7) completed the Type D Scale
at baseline; patients also completed the Hospital Anxiety and Depression Scale at baseline and
6 months post-implantation.
Results: ANOVA for repeated measures, using the Type D main effects and the interaction effect,
showed that the interaction timebyTypeDpatient byTypeDpartnerwas significant (F(1,277)=7.0,
p=.009) for depression as outcome, but not for anxiety (F(1,277)=3.1, p=.08). Post-hoc
comparisons revealed that Type D patients with a Type D partner (n=23/281, 8.2%) experienced
the highest depression levels compared to other personality combinations (all psb .05).
Limitations: The group of Type D patients with a Type D partner was rather small.
Conclusions: ICD patients with a Type D personality report more depressive symptoms, but not
anxiety, if the partner also has a Type D personality. This may be due to poor communication and
lack of emotional support in the relationship. These results emphasize the importance of taking
into account the psychological profile of the partner in the management and care of the ICD
patient, and to direct behavioural support not only at the ICD patient but also at the partner.
© 2010 Elsevier B.V. Open access under the Elsevier OA license.Keywords:
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Spouses1. Introduction
The implantable cardioverter deﬁbrillator (ICD) is
implanted in patients who have experienced a sudden cardiac
arrest (secondary prevention) and in patients who are at risk
for a sudden cardiac arrest, due to a decreased ejection
fraction (primary prevention) (Epstein et al., 2008). TheMedical Psychology,
he Netherlands. Tel.:
).
lsevier OA license.medical beneﬁts of the ICD over pharmacological therapy are
unequivocal in preventing sudden cardiac death in most
patients (Ezekowitz et al., 2003), but adaptation problems
exist in 25% to 33% of ICD patients who experience increased
emotional distress (Bilge et al., 2006; Van den Broek et al.,
2008), which in turn may trigger new life-threatening
arrhythmias (Van den Broek et al., 2009; Whang et al.,
2005) and inﬂuence survival (Ladwig et al., 2008; Steinberg et
al., 2008; Pedersen et al., 2010). These emotional problems
may be more related to the psychological proﬁle of the
patient than to clinical factors, such as indication for the ICD,
ICD shocks, or an ICD advisory (Bilge et al., 2006; Pedersen et
al., 2007, 2009a, 2010; Van den Broek et al., 2008).
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factors. In a mixed sample of post-myocardial infarction
patients and ICD patients, patients with a Type D (distressed)
personality without a partner showed higher distress levels
than Type D patients with a partner (Van den Broek et al.,
2007). Higher distress levels in cardiac patients have also
been related to higher distress levels in their partners (Pihl
et al., 2005), and research has shown that partner distress
levels can be as high as distress levels in patients with an ICD
(Pedersen et al., 2009b). In addition, lower survival rates
were found in cardiac patients who reported low marital
quality (Rohrbaugh et al., 2006). However, research has not
focused on the inﬂuence of other partner characteristics, such
as the personality of the partner, on patient distress.
The distressed (Type D) personality refers to the joint
presence of two broad and normal personality traits, namely
negative affectivity and social inhibition (Denollet, 2005).
Persons with high levels of negative affectivity experience a
broad range of negative emotions across time and situations.
These persons generally have a gloomy view of themselves
and the world. A high level of social inhibition refers to
avoidance of social interactions, mainly because of fear of
disapproval by others. Hence, Type D individuals are inclined
to keep their negative feelings to themselves and not express
them. Research, which has been performed primarily in
cardiac populations, has shown that Type D patients are at
increased risk for morbidity and mortality (Pedersen and
Denollet, 2006). Speciﬁcally in ICD patients, Type D person-
ality is associated with increased emotional distress (Van den
Broek et al., 2007, 2008), impaired quality of life (Pedersen et
al., 2007), and also with new life-threatening arrhythmias
(Van den Broek et al., 2009) and mortality (Pedersen et al.,
2010). Little is known about the impact of both the patient
and his/her partner having a Type D personality. This
combination may incur the highest risk for distress because
both individuals experience high levels of negative emotions,
but at the same time they do not disclose their emotions,
resulting in poor communication and lack of social support in
the patient–partner dyad.
Hence, the objective of this prospective study was to
examine the impact of concordant vs. discordant personality
types (i.e., Type D personality) of the patient and the partner
on symptoms of depression and anxiety in patients with an
ICD. We hypothesized that the personality of the partner
would inﬂuence distress levels in the patient, and that the
highest distress levels would be found in Type D patients
whose partner also has a Type D personality.
2. Method
2.1. Study design and participants
The sample for this study comprised consecutive patients
receiving an ICD implantation between August 2003 and
December 2008 at the Erasmus Medical Center, Rotterdam,
The Netherlands, and their partners. All patients and partners
participated in the ongoing Mood and personality as
precipitants of arrhythmia in patients with an Implantable
cardioverter Deﬁbrillator: A prospective Study (MIDAS).
Exclusion criteria were a life expectancy of less than 1 year,
on the waiting list for heart transplantation, a history ofpsychiatric illness other than affective/anxiety disorders (i.e.,
a mental disorder involving abnormal moods and emotions),
or with insufﬁcient knowledge of the Dutch language.
During clinical visits to the hospital, patients and their
partners were asked to complete a set of standardized and
validated psychological questionnaires at baseline (i.e., one
day prior to ICD implantation) and at a 6 month follow-up.
Only patient and partner dyads with complete data were
included in the statistical analyses.
The MIDAS study protocol was approved by the medical
ethics committee of the Erasmus Medical Center. The study
was conducted conform to the ethical tenets developed by
the World Medical Association, as espoused in the Declara-
tion of Helsinki. All patients provided written informed
consent.
2.2. Materials
2.2.1. Demographic and clinical variables
Demographic and clinical variables were obtained at
baseline from the patients' medical records and through
purpose-designed questions. Demographic variables included
gender, age, education (secondary school or less vs. high
school/university), and working status. Clinical variables
included indication for ICD implantation (primary vs. second-
ary prevention), cardiac resynchronization therapy (CRT),
coronary artery disease (CAD) etiology, heart failure, diabetes
mellitus, smoking, cardiac and psychotropic medication, and
shocks (both appropriate and inappropriate) during the 6-
month follow-up period.
2.2.2. Type D personality
At baseline, both patients and partners completed the 14-
item Type D Scale (DS14) to assess Type D personality
(Denollet, 2005). The DS14 consists of two subscales, negative
affectivity (e.g., ‘I often feel unhappy’) and social inhibition
(e.g., ‘I am a closed kind of person’), each comprising 7 items.
Items are answered on a 5-point Likert scale ranging from 0
(false) to 4 (true), with total scores ranging from 0 to 28 for
both subscales. The patient had to complete at least 6 out
of 7 items per subscale to be included in statistical analyses,
with the 7th item being replaced by the mean of the other 6
scores. Patients scoring high on both subscales according to a
standardized cut-off score≥10 are classiﬁed as Type D
(Denollet, 2005; Emons et al., 2007). The DS14 is a valid
and reliable scale with Cronbach's alphas of 0.88 and 0.86 and
a high test–retest reliability over a 3-month period of r=0.72
and 0.82 for the negative affectivity and social inhibition
subscales, respectively (Denollet, 2005). A study in post-
myocardial infarction patients demonstrated that the DS14 is
a stable personality measure over an 18-month period and
that scores are not confounded by indicators of disease
severity (Martens et al., 2007).
2.2.3. Depression and anxiety
Symptoms of depression and anxiety were measured with
the Hospital Anxiety and Depression Scale (HADS), a self-
report questionnaire with a 7-item anxiety and 7-item
depression subscale (Zigmond and Snaith, 1983). Items are
scored on a 4-point Likert scale ranging from 0 to 3, with a
score range of 0–21 for both subscales. Patients had to ﬁll in at
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mean imputation begin used for the missing 7th item. The
Dutch version of the HADS has been shown to be valid and
reliable, with Cronbach's alphas ranging from 0.71 to 0.86 for
the depression subscale and from 0.80 to 0.84 for the anxiety
subscale, and the test–retest reliability being 0.86 and 0.89,
respectively (Spinhoven et al., 1997). Patients completed the
HADS at baseline and at the 6 month follow-up.2.3. Statistical analyses
To examine differences in baseline characteristics strati-
ﬁed by concordant and discordant Type D status of patients
and their partners, we used the Chi-square test for discrete
variables and analysis of variance (ANOVA), with post-hoc
Bonferroni testing if applicable, for continuous variables.
The independent impact of Type D personality of the
patient and partner on patients' depression and anxiety levels
was examined by ANOVA for repeated measures with Type D
personality of the patient, Type D personality of the partner,
and their interaction as between-subject factors. When we
found a signiﬁcant three- or two-way interaction effect, we
did not report on the main effects. Instead, we performed
post-hoc analyses with a Games-Howell (for unequal groups
with unequal variances) or Hochberg T2 correction (for
unequal groups with equal variances) to examine the
differences between groups based on the combined Type D
status of the patients and their partners. Also, paired-sample
T-tests were used to examine changes in depression and
anxiety levels during follow-up. When we did not found a
signiﬁcant interaction effect, we reran the ANOVA without
the interaction term.
Analysis of covariance (ANCOVA) for repeated measures
was performed to adjust for the potential confounding effects
of age, gender, education (secondary school or less vs. high
school/university), ICD indication (primary vs. secondary),Approached patients 
Patients without a partner
Patients who died before follow-up 
Patients with missing data on 
questionnaires N
Partners who refused or had 
missing data on questionnaires 
Patients with missing data on 
demographic or clinical variables N
sesylananidedulcnistneitaP
Fig. 1. Flow-chart oCRT, CAD, heart failure, shocks (0 vs. z1), diabetes, psycho-
tropic medication, and smoking.
All tests were two-tailed and pb.05 was used to indicate
statistical signiﬁcance. All data were analyzed using SPSS.17.0
for Windows (SPSS Inc., Chicago, Illinois).
3. Results
3.1. Baseline characteristics for the total group and stratiﬁed by
the personality of the patient and the partner
In total, 391 patients were approached, of which 281 could
be included in the current analyses (see Fig. 1 for aﬂow-chart of
the sample selection). Themean age of the partnerswas 56.5±
11.7 and 20.6% of partners were male. In total, 20 patients had
received at least one ICD shock, with 5 patients receiving
inappropriate shock(s) only, 14 patients appropriate shock(s)
only, and 1 patient both. Demographic and clinical character-
istics for the total sample and stratiﬁed by four groups based on
Type D status of patients and their partners are presented in
Table 1. The ﬁrst group comprised non-Type D patients with
non-Type D partners (n=172, 61.2%), the second group non-
Type D patients with Type D partners (n=51, 18.1%), the third
group Type D patients with non-Type D partners (n=35,
12.5%) and the fourth group Type D patients with Type D
partners (n=23, 8.2%). The four groups did not differ
systematically on any of the demographic or clinical variables.
3.2. Depression
ANOVA for repeated measures showed that the three-
way interaction time by Type D patient by Type D partner
was signiﬁcant (F(1,277)=7.0, p=.009). Post-hoc analyses
were performed to examine the differences in depression
levels between the four groups (Fig. 2). Type D patients with
Type D partners had signiﬁcantly higher baseline levels
of depression compared to the other three groups (allN=391 
N=26
N=345 (100%) 
N=9 (2.6%) 
=39 (11.3%) 
N=6 (2.4%) 
=10 (2.9%)  
N=281 (81.4%)
f the study.
Table 1
Demographic and clinical characteristics of ICD patients stratiﬁed by Type D personality status of patient and partnera.
Total
N=281
Non-TD patient
Non-TD partner
n=172
Non-TD patient
TD partner
n=51
TD patient
Non-TD partner
n=35
TD patient
TD partner
n=23
p
Demographics
Age, mean (SD) 58.3 (11.0) 58.5 (10.9) 56.0 (12.1) 58.2 (9.6) 61.6 (10.7) .23
Female gender 56 (19.9) 35 (20.3) 11 (21.6) 8 (22.9) 2 (8.7) .55
Secondary school or less 160 (56.9) 97 (56.4) 30 (58.8) 20 (57.1) 13 (56.5) .99
Currently employed 110 (39.1) 66 (38.4) 24 (47.1) 13 (37.1) 7 (30.4) .54
Clinical factors
Primary indication 184 (65.5) 112 (65.1) 31 (60.8) 24 (68.6) 17 (73.9) .71
CRT 80 (28.5) 47 (27.3) 14 (27.5) 12 (34.3) 7 (30.4) .86
CAD 161 (57.3) 99 (57.6) 25 (49.0) 19 (54.3) 18 (78.8) .13
Heart failure 112 (39.9) 69 (40.1) 17 (33.3) 17 (48.6) 9 (39.1) .57
Diabetes mellitus 38 (13.5) 20 (11.6) 9 (17.6) 5 (14.3) 4 (17.4) .67
Smoking 28 (10.0) 18 (10.5) 4 (7.8) 3 (8.6) 3 (13.0) .89
Medication
Amiodarone 54 (19.2) 31 (18.0) 14 (27.5) 3 (8.6) 6 (26.1) .13
Beta-blockers 222 (79.0) 134 (77.9) 43 (84.3) 28 (80.0) 17 (73.9) .71
Digoxin 42 (14.9) 28 (16.3) 6 (11.8) 5 (14.3) 3 (13.0) .87
Statins 165 (58.7) 97 (56.4) 28 (54.9) 21 (60.0) 19 (82.6) .11
ACE-inhibitors 197 (70.1) 120 (69.8) 33 (64.7) 26 (74.3) 18 (78.3) .63
Diuretics 153 (54.4) 93 (54.1) 25 (49.0) 23 (65.7) 12 (52.2) .48
Psychopharmaca 47 (16.7) 26 (15.1) 6 (11.8) 10 (28.6) 5 (21.7) .16
aResults are presented as n (%), unless otherwise stated.
CAD = coronary artery disease; CRT = cardiac resynchronization therapy.
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signiﬁcantly higher baseline depression levels compared to
the non-Type D patients with (group 2; mean differ-
ence=2.7, p=.003) and without (group 1; mean differ-
ence=2.6, p=.001) a Type D partner. Baseline depression
levels for non-Type D patients with and without a Type D
partner were not signiﬁcantly different (mean difference=
−0.1, p=1.00). Paired-sample T-test showed that Type D
patients with Type D partners and non-Type D patients with
non-Type D partners experienced a signiﬁcant decrease in
depression levels during follow-up (mean difference=2.2,
p=.007, and mean difference=0.8, p=.001, respectively),
while the depression levels in the other two groups
remained stable over time. At 6 months, there was only a
borderline signiﬁcant difference between depression levels
of Type D patients with and without a Type D partner (mean
difference=2.4, p=.06).Fig. 2. Mean depression levels in ICD patients stratiﬁed b3.3. Anxiety
For anxiety, the time by Type D patient by Type D partner
(F(1,277)=3.1, p=.08) and the Type D patient by Type D
partner interaction effects were not signiﬁcant (F(1,277)=2.6,
p=.11). In the ANOVA without the interaction term,
between-subject effects for Type D patients (F(1,278)=47.1,
pb .001) and Type D partners (F(1,278)=6.03, p=.02) were
signiﬁcant, indicating that the personality of the patient as
well as the personality of the partner exerted a main
inﬂuence on anxiety levels in the patient, with Type D
patients and ICD patients with a Type D partner experiencing
more anxiety than their counterparts (Fig. 3). Anxiety levels
declined signiﬁcantly over the 6 month follow-up period
(F(1,278)=30.2, pb.001). This decline was not related to the
speciﬁc personality type of patients nor partners (F(1,278)=
2.4, p=.12, and F(1,278)=0.1, p=.75, respectively)y Type D personality status of patient and partner.
Fig. 3. Mean anxiety levels in ICD patients stratiﬁed by Type D personality status of patient and partner.
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Our main results did not change in adjusted analyses.
Between-subject effects of covariates showed that depression
and anxiety levels were signiﬁcantly different according to
educational level (F(1,266)=10.8, p=.001, and F(1,267)=9.7,
p=.002, respectively) and use of psychopharmaca (F(1,266)=
7.2, p=.007, and F(1,267)=21.8, pb .001, respectively), with
plots showing increased depression and anxiety levels in
patients with lower education and in patients who use
psychopharmaca. Shocks were neither signiﬁcantly associat-
ed with depression nor anxiety levels (F(1,266)=0.5, p=.48
and F(1,267)=2.9, p=.09).
4. Discussion
The ﬁndings of the current prospective study showed that
not only the personality of the patient but also the
combination with the partner's personality inﬂuenced de-
pression levels in ICD patients, with Type D patients with a
Type D partner experiencing the highest depression levels
compared to other personality combinations. These patients
also showed the largest decline in depression levels within
6 months post-ICD implantation. There was no effect of
patient/partner personality combination on anxiety, but both
patient and partner personality types did exert a main effect
on anxiety. This indicates that anxiety levels in Type D
patients were higher than in non-Type D patients, but that it
did not matter whether the partner was Type D or not, and
also that anxiety levels were higher in ICD patients who had a
Type D partner compared to ICD patients who did not have a
Type D partner, but that the Type D status of the patient did
not have additional value in these two groups.
Our ﬁnding that personality of the partner may inﬂuence
distress levels in patients is in line with previous studies that
also focused on the impact of partner factors on patient well-
being, although none of the previous studies speciﬁcally
focused on the personality of the partner. For instance, Moser
and Dracup (2004) reported that anxiety in spouses was
positively related to emotional distress in cardiac patients.
Distress in partners has also been shown to inﬂuence survival
in patients (Rohrbaugh et al., 2006). Finally, studies have
shown that distress in partners of patients with a chronic
disease is associated with poor health status in partners,through prolonged sympathetic activation and pronounced
platelet activation (Aschbacher et al., 2008) and impaired
endothelial function (Mausbach et al., 2010) in partners.
We do not know why Type D patients with a Type D
partner are particularly vulnerable for developing depression,
but can only speculate that it has to do with a number of
factors that hamper communication in the patient–partner
dyad. Generally, individuals with a Type D personality have a
gloomy view of life and therefore, may view the ICD
implantation as a negative event. Hence, both the Type D
patient and the Type D partner may feel frustrated but at the
same time are not willing to discuss the impact of living with
an ICD on their lives. For this reason, it is unlikely that a Type
D partner will ask the patient how he/she feels in order to
avoid instilling conversations about fear. In addition, the
patient is unlikely to be forthcoming with his/her uncertain-
ties and worries. Due to misconstrued consideration and lack
of communication, the Type D patient and the Type D partner
may not be able to disclose their negative feelings within the
boundaries of their relationship. Lack of support in combina-
tion with frustration may lead to depression, as lack of
support is a known risk factor for increased emotional
distress and adverse clinical events, such as mortality (Barth
et al., 2010).
We can only speculate why the combination of personal-
ities seems to play no role in relation to anxiety. Perhaps it has
to dowith the type of emotion, with symptoms of anxiety and
depression differing in their manifestations both at a
behavioural and physiological level. Anxiety symptoms are
more difﬁcult to hide and therefore are more visible than
depressive symptoms, making it more evident that the
patient is distressed.
Our longitudinal ﬁndings reﬂected a general decline in
depression and anxiety levels within 6 months following ICD
implantation, which has also been shown by others (Kapa
et al., 2010). Type D patients with a non-Type D partner
showed the largest decline in depression levels. This may
reﬂect a real decline and not just regression to the mean, as
the group non-Type D patients with non-Type D partners,
who had the lowest depression levels, also showed a
signiﬁcant decline. The largest decline in the Type D
patient–partner dyad may be attributed to Type D patients
receiving extra attention from family and friends following
the implantation, thereby encouraging them to express
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refrain from talking about their negative feelings, this
encouragement from signiﬁcant others together with the
fact that they have just undergone amajor life event – the ICD
implantation – may help them bridge their using fear of
talking about their emotions. In addition, given that these
patients had the highest level of depression, there was more
room for improvement in this group compared to the other
groups.
In the current study, shocks were unrelated to depression
and anxiety. Although ICD shocks tend to be viewed as the
primary culprit if patients become anxious or experience a
deterioration in quality of life (Raitt, 2008), a recent
viewpoint indicates that evidence for a role of shocks on
anxiety, depression and quality of life in the general
arrhythmia literature is mixed and perhaps more complex
than previously assumed (Pedersen et al., 2010). Due to the
limited number of patients having received a shock during
the follow-up period, it was not possible to differentiate
appropriate from inappropriate shocks, although these may
have a differential effect on emotional distress. Similarly, a
focus on the number of shocks may be warranted, as the
Canadian Implantable Deﬁbrillator Study showed a dose-
relationship between shocks and quality of life (Irvine et al.,
2002), although none of the other primary and secondary
prevention trials conﬁrmed this dose–response relationship
(Pedersen et al., 2010).
The limitations of the current study should be acknowl-
edged. First, baseline assessment was one day prior to
implantation, which may have resulted in more increased
anxiety and depression scores, due to anticipatory anxiety.
For logistic reasons, it was not feasible to administer
questionnaires prior to one day before implantation. Some
patients know several weeks in advance that they will have
an ICD implanted, while others receive an ICD acutely
following a large infarction or a sudden cardiac rest. Given
that all patients are admitted one day prior to implantation,
this time point was chosen in order standardize the baseline
assessment. Second, the follow-up period was limited to
6 months. Third, anxiety was measured using a general
measure instead of a disease-speciﬁc measure. However,
the HADS is less prone to confounding by disease severity, as
the HADS does not include somatic items (Zigmond and
Snaith, 1983). Fourth, the prevalence of shocks was rather
low, making it difﬁcult to draw ﬁrm conclusions about the
impact of shocks on distress levels. Finally, the group of Type
D patients and Type D partners was rather small. Despite
these limitations, to our knowledge, this is the largest study to
date of patient and partner dyads with an ICD and the only
study to have examined the inﬂuence of both the personality
of the patient and the partner on patient distress levels.
Future studies are warranted to replicate the ﬁndings of
our study, and also to examine the impact of the partner's
personality in combination with the personality of the patient
on patientmorbidity andmortality, as several studies indicate
that poor marital quality is related to mortality in patients
(Rohrbaugh et al., 2006). In addition, research is warranted
that examines the pathways through which combinations of
personality in patients and partners may lead to increased
emotional distress in patients, in order to be able to develop
effective interventions.These results emphasize the importance of taking into
account the psychological proﬁle of the partner in the
management and care of the ICD patient. Currently, partners
of patients with somatic disease tend to be neglected, as the
main focus is on treatment of the ICD patient. Health care
professionals should also be alert to the uncertainties and
distress of partners, with the provision of adequate informa-
tion and support being of primary importance. This can be
achieved by inviting partners to participate in cardiac
rehabilitation, as advocated by others (Lewin et al., 2001),
which provides a forum for discussing emotional and
practical aspects. Extra attention to Type D couples or couples
with one Type D person may include encouragement to
communicate with each other and to talk about uncertainties.
In conclusion, depressive symptoms were highest in ICD
patients with a Type D personality if the partner also had a
Type D personality, although this effect was not found with
respect to anxiety. Future research is warranted to replicate
these ﬁndings and investigate mechanisms and targets for
intervention. Nevertheless, these results indicate that beha-
vioural support should be directed not only at the ICD patient
but also the partner.
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